Citation Impact

50 standout
Sub-graph 1 of 25

Citing Papers

The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
2 intermediate papers

Works of Michelle Mott being referenced

A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma
2015
Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma
2015

Author Peers

Author PFM Oncology RNMI Neurology Last Decade Papers Cites
Michelle Mott 146 131 6 62 8 210
Toshiro Suzawa 1 17 1 61 930
Kung‐Chu Ho 51 129 484 11 35 940
Ebony Ruhland 1 25 579
Yuzhong Yan 2 19 8 4 33 231
F. Nishikido 153 18 350

All Works

Loading papers...

Rankless by CCL
2026